HRP20120930T1 - Cjepivo protiv hpv16 i hpv18 i još najmanje jednog tipa hpv, kojeg se bira između hpv31, 45 ili 52 - Google Patents
Cjepivo protiv hpv16 i hpv18 i još najmanje jednog tipa hpv, kojeg se bira između hpv31, 45 ili 52 Download PDFInfo
- Publication number
- HRP20120930T1 HRP20120930T1 HRP20120930TT HRP20120930T HRP20120930T1 HR P20120930 T1 HRP20120930 T1 HR P20120930T1 HR P20120930T T HRP20120930T T HR P20120930TT HR P20120930 T HRP20120930 T HR P20120930T HR P20120930 T1 HRP20120930 T1 HR P20120930T1
- Authority
- HR
- Croatia
- Prior art keywords
- hpv
- preparation according
- cancer
- type
- adjuvant
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 7
- 201000011510 cancer Diseases 0.000 claims 7
- 239000002671 adjuvant Substances 0.000 claims 6
- 230000002163 immunogen Effects 0.000 claims 6
- 208000003837 Second Primary Neoplasms Diseases 0.000 claims 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical group [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 1
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical group O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0413510.9A GB0413510D0 (en) | 2004-06-16 | 2004-06-16 | Vaccine |
US11/114,301 US20050287161A1 (en) | 2002-12-20 | 2005-04-26 | Vaccine |
PCT/EP2005/006461 WO2005123125A1 (en) | 2004-06-16 | 2005-06-14 | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20120930T1 true HRP20120930T1 (hr) | 2012-12-31 |
Family
ID=32750044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20120930TT HRP20120930T1 (hr) | 2004-06-16 | 2012-11-16 | Cjepivo protiv hpv16 i hpv18 i još najmanje jednog tipa hpv, kojeg se bira između hpv31, 45 ili 52 |
Country Status (15)
Country | Link |
---|---|
JP (1) | JP2012102132A (nl) |
KR (1) | KR101359943B1 (nl) |
CN (1) | CN1976718B (nl) |
CY (1) | CY1113830T1 (nl) |
DK (1) | DK1758609T3 (nl) |
ES (1) | ES2394448T3 (nl) |
GB (1) | GB0413510D0 (nl) |
HR (1) | HRP20120930T1 (nl) |
HU (3) | HUS1500060I1 (nl) |
LT (1) | LTC1758609I2 (nl) |
NL (3) | NL300771I2 (nl) |
PT (1) | PT1758609E (nl) |
SI (1) | SI1758609T1 (nl) |
TW (1) | TW200612983A (nl) |
ZA (1) | ZA200610057B (nl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2416798B1 (en) * | 2009-04-10 | 2017-09-20 | The Johns Hopkins University | Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
EP2593548A4 (en) * | 2010-07-15 | 2013-11-27 | British Columbia Cancer Agency | ANTIGEN E7 COMPOSITIONS OF HUMAN PAPILLOMAVIRUS AND USES THEREOF |
CN107188966B (zh) | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | 一种乳头瘤病毒嵌合蛋白及其用途 |
CN114539365B (zh) * | 2020-11-26 | 2023-12-01 | 中国医学科学院基础医学研究所 | 一种改造的人乳头瘤病毒52型l1蛋白及其用途 |
CN114716561B (zh) | 2021-01-04 | 2024-03-12 | 中国医学科学院基础医学研究所 | 一种人乳头瘤病毒31型嵌合蛋白及其用途 |
CN114716560B (zh) | 2021-01-04 | 2024-02-02 | 中国医学科学院基础医学研究所 | 一种人乳头瘤病毒18型嵌合蛋白及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9921147D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
GB0110431D0 (en) * | 2001-04-27 | 2001-06-20 | Glaxosmithkline Biolog Sa | Novel compounds |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206359D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
-
2004
- 2004-06-16 GB GBGB0413510.9A patent/GB0413510D0/en not_active Ceased
-
2005
- 2005-06-14 CN CN2005800195155A patent/CN1976718B/zh active Active
- 2005-06-14 SI SI200531633T patent/SI1758609T1/sl unknown
- 2005-06-14 PT PT57579534T patent/PT1758609E/pt unknown
- 2005-06-14 TW TW094119691A patent/TW200612983A/zh unknown
- 2005-06-14 ES ES05757953T patent/ES2394448T3/es active Active
- 2005-06-14 KR KR1020127027786A patent/KR101359943B1/ko active IP Right Grant
- 2005-06-14 DK DK05757953.4T patent/DK1758609T3/da active
-
2006
- 2006-11-30 ZA ZA200610057A patent/ZA200610057B/en unknown
-
2012
- 2012-01-06 JP JP2012001102A patent/JP2012102132A/ja active Pending
- 2012-11-16 HR HRP20120930TT patent/HRP20120930T1/hr unknown
- 2012-12-11 CY CY20121101211T patent/CY1113830T1/el unknown
-
2015
- 2015-11-30 NL NL300771C patent/NL300771I2/nl unknown
- 2015-11-30 NL NL300774C patent/NL300774I1/nl unknown
- 2015-11-30 NL NL300773C patent/NL300773I1/nl unknown
- 2015-12-01 HU HUS1500060C patent/HUS1500060I1/hu unknown
- 2015-12-01 HU HUS1500059C patent/HUS1500059I1/hu unknown
- 2015-12-01 HU HUS1500061C patent/HUS1500061I1/hu unknown
- 2015-12-07 LT LTPA2015046C patent/LTC1758609I2/lt unknown
Also Published As
Publication number | Publication date |
---|---|
PT1758609E (pt) | 2012-12-21 |
NL300771I1 (nl) | 2015-12-29 |
CN1976718B (zh) | 2012-10-10 |
HUS1500061I1 (hu) | 2016-01-28 |
NL300774I2 (nl) | 2015-12-29 |
NL300771I2 (nl) | 2015-12-29 |
LTC1758609I2 (lt) | 2017-05-10 |
CN1976718A (zh) | 2007-06-06 |
TW200612983A (en) | 2006-05-01 |
ZA200610057B (en) | 2008-02-27 |
KR101359943B1 (ko) | 2014-02-10 |
HUS1500060I1 (hu) | 2017-10-30 |
ES2394448T3 (es) | 2013-01-31 |
CY1113830T1 (el) | 2016-06-22 |
SI1758609T1 (sl) | 2013-01-31 |
NL300773I2 (nl) | 2015-12-29 |
GB0413510D0 (en) | 2004-07-21 |
NL300774I1 (nl) | 2015-12-29 |
KR20120123617A (ko) | 2012-11-08 |
JP2012102132A (ja) | 2012-05-31 |
NL300773I1 (nl) | 2015-12-29 |
HUS1500059I1 (hu) | 2017-10-30 |
DK1758609T3 (da) | 2012-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20120930T1 (hr) | Cjepivo protiv hpv16 i hpv18 i još najmanje jednog tipa hpv, kojeg se bira između hpv31, 45 ili 52 | |
EP2444103A4 (en) | VACCINE AGAINST NUTRITIONAL CANCER | |
Schwarz et al. | Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: improving upon nature | |
JP2006512413A5 (nl) | ||
Frazer | Development and implementation of papillomavirus prophylactic vaccines | |
BRPI0810959A2 (pt) | "proteína l1 do hpv11, polinucleotídeo, vetor, célula, composição, partícular semelhante ao vírus (vlp) hp11, método para produzir uma proteína l1 do hpv,vacina para prevenção de condiloma acuminado ou de infecções por hpv, uso da proteína método para prevenção de condiloma acuminado ou infecções por hpv e método para prevenção de condiloma acuminado ou infecções por hpv. | |
RU2006143804A (ru) | Вакцина против вирусов папилломы человека hpv16 и hpv18 и по меньшей мере еще одного типа hpv, выбранного из hpv 31,45 или 52 | |
EA201190327A1 (ru) | Новые конструкции белка вируса папилломы человека (hpv) и их применение в предупреждении заболевания, вызываемого hpv | |
AR022510A1 (es) | Formulaciones de vacunas contra el papilomavirus humano | |
JP2005270111A (ja) | パピローマウイルス様粒子、融合タンパク質並びにそれらの製造方法 | |
JP2015504897A5 (nl) | ||
TR201908199T4 (tr) | HPV'ye karşı aşılar. | |
AR051023A1 (es) | Vacunas que contienen antigeno de plasmodium | |
CA2633266A1 (en) | Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same | |
JP2011529475A5 (nl) | ||
JP2010530362A5 (nl) | ||
BR112018011331A2 (pt) | mutante de proteìna l1 de papillomavirus humano tipo 11 | |
WO2004056389A1 (en) | Hpv-16 and -18 l1 vlp vaccine | |
ECSP22063122A (es) | Vacuna contra hpv | |
WO2010012069A8 (en) | Multivalent vaccines based on papaya mosaic virus and uses thereof | |
JP2018501322A5 (nl) | ||
JP2018532806A5 (nl) | ||
WO2022150661A3 (en) | Monovalent and multivalent vaccines for prevention and treatment of disease | |
WO1999061052A3 (en) | Oral immunization with papillomavirus virus-like particles | |
RU2017130274A (ru) | Композиция, содержащая молочнокислые бактерии, пероральная фармацевтическая композиция для лечения hpv инфекции и/или hpv-ассоциированных опухолей и средство, индуцирующее мукозальный иммунитет |